El Salvador: Over Pricing of Medicines

The pharmaceutical industry claims that the Ministry of Health paid 160% more for drugs purchased from foreign suppliers and that there is no transparency in tenders.

Wednesday, April 30, 2014

The Association of Chemical-Pharmaceutical Industrialists in El Salvador, INQUIFAR, reports that since 2011 the Ministry of Health has shifted away from the domestic industry in the purchase of medicines for the public hospital network, making direct contracts and demanding manufacturing rules that are specific to other countries and not those in force in the country.

In an interview elsalvador.com, Carmen Prez, President of INQUIFAR, said: "We use to have an almost 50% share of the purchases from the Ministry of Health per year, it is now less than 20%" ... It seems unfair that they favor foreign laboratories, giving a higher score for complying with the current standards in each of their countries ... they are also paying them more money."

"There is lack of transparency in recruitment processes, as there is no public opening of bids or notification of the codes won by each company and they only give one hour to review the file, with the aggravating circumstance that do not allow the presentation of petitions for review, giving total freedom to the administration to make the award according to its own will," she said.



More on this topic

Rejection of Chinese Medicines

January 2019

Arguing a possible dumping problem, the pharmaceuticals guild in El Salvador opposes a medicine purchase that the Social Security Institute plans to make from a company in China.

The Association of Chemical-Pharmaceutical Industries of El Salvador (Inquifar) reported that the Salvadoran Institute of Social Security (ISSS) seeks to buy medicines and supplies from a company in China, because they expect that the quality of medicine would be put at risk.

Perspectives for the Pharmaceutical Sector

August 2018

In El Salvador, companies in the pharmaceutical industry plan to achieve 5% growth in exports of their products this year.

A rebound in sales to Honduras and the opening of new markets is what is behind the projection of growth that the Association of Chemical-Pharmaceutical Manufacturers of El Salvador (INQUIFAR) has for this year.

El Salvador: Pharmaceutical Exports Booming

May 2016

Next year the sector expects to exceed the 12% growth in sales abroad seen between 2014 and 2015, by going to new markets in Africa and South America.

On top of the 12% growth in the export of medicines and other pharmaceutical products there was also greater participation in government procurements, which according to the Chemical Pharmaceutical Industry Association of El Salvador (Inquifar), "...

El Salvador: Local vs. Foreign Pharmaceutical Companies

June 2015

Salvadoran laboratories and drug suppliers are complaining that in their purchases the government favors foreign companies over national ones.

The Association of Chemical Industrial Pharmaceutical Companies in El Salvador (Inquifar) states that a change made in the law, which allows the Ministry of Health to make direct contracts rather than tenders, is the reason behind the exclusion of domestic enterprises from drug purchases .

 close (x)

Receive more news about Health & Medicine

Suscribe FOR FREE to CentralAmericaDATA EXPRESS.
The most important news of Central America, every day.

Type in your e-mail address:

* Al suscribirse, estará aceptando los terminos y condiciones


Stock Indexes

(Apr 6)
Dow Jones
-5.60%
S&P 500
-5.10%
Nasdaq
-5.64%

Commodities

(Jan 21)
Brent Crude Oil
87.070
Coffee "C"
237.55
Gold
1,836
Silver
24.26